Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Farber disease with prolonged survival

  • 38 Accesses

  • 9 Citations

This is a preview of subscription content, log in to check access.

References

  1. Barrier H, Gillot F (1973) La lipogranulomatose de Farber.Nouv Press Med 2: 767–770.

  2. Pavone L, Moser HW, Mollica F, Reitano G, Durand P (1980) Farber's lipogranulomatosis: ceramidase deficiency and prolonged survival in three relatives.Johns Hopkins Med J 147: 193–196.

  3. Samuelsson K, Zetterstrom R (1971) Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course.Scand J Clin Lab Invest 27: 393–405.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fiumara, A., Nigro, F., Pavone, L. et al. Farber disease with prolonged survival. J Inherit Metab Dis 16, 915–916 (1993). https://doi.org/10.1007/BF00714300

Download citation

Keywords

  • Public Health
  • Internal Medicine
  • Prolonged Survival